↓ Skip to main content

Dove Medical Press

Article Metrics

Early and intermediate age-related macular degeneration: update and clinical review

Overview of attention for article published in Clinical Interventions in Aging, October 2017
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
55 Mendeley
Title
Early and intermediate age-related macular degeneration: update and clinical review
Published in
Clinical Interventions in Aging, October 2017
DOI 10.2147/cia.s142685
Pubmed ID
Authors

Alfredo Garcia-Layana, Franciso Cabrera-López, José García-Arumí, Lluís Arias-Barquet, José M Ruiz-Moreno

Abstract

Age-related macular degeneration (AMD) is the leading cause of irreversible central vision loss in developed countries. With the aging of population, AMD will become globally an increasingly important and prevalent disease worldwide. It is a complex disease whose etiology is associated with both genetic and environmental risk factors. An extensive decline in the quality of life and progressive need of daily living assistance resulting from AMD among those most severely affected highlights the essential role of preventive strategies, particularly advising patients to quit smoking. In addition, maintaining a healthy diet, controlling other risk factors (such as hypertension, obesity, and atherosclerosis), and the use of nutritional supplements (antioxidants) are recommendable. Genetic testing may be especially important in patients with a family history of AMD. Recently, unifying criteria for the clinical classification of AMD, defining no apparent aging changes; normal aging changes; and early, intermediate, and late AMD stages, are of value in predicting AMD risk of progression and in establishing recommendations for the diagnosis, therapeutic approach, and follow-up of patients. The present review is focused on early and intermediate AMD and presents a description of the clinical characteristics and ophthalmological findings for these stages, together with algorithms for the diagnosis and management of patients, which are easily applicable in daily clinical practice.

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 55 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 13 24%
Student > Ph. D. Student 12 22%
Student > Master 10 18%
Student > Bachelor 6 11%
Student > Doctoral Student 4 7%
Other 10 18%
Readers by discipline Count As %
Unspecified 15 27%
Medicine and Dentistry 14 25%
Biochemistry, Genetics and Molecular Biology 5 9%
Nursing and Health Professions 5 9%
Agricultural and Biological Sciences 5 9%
Other 11 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2018.
All research outputs
#10,540,714
of 11,895,637 outputs
Outputs from Clinical Interventions in Aging
#1,132
of 1,212 outputs
Outputs of similar age
#238,357
of 284,292 outputs
Outputs of similar age from Clinical Interventions in Aging
#56
of 57 outputs
Altmetric has tracked 11,895,637 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,212 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 284,292 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.